1. Academic Validation
  2. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia

Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia

  • Am J Hum Genet. 2013 Jul 11;93(1):118-23. doi: 10.1016/j.ajhg.2013.05.006.
Amir Boukhris 1 Rebecca Schule José L Loureiro Charles Marques Lourenço Emeline Mundwiller Michael A Gonzalez Perrine Charles Julie Gauthier Imen Rekik Rafael F Acosta Lebrigio Marion Gaussen Fiorella Speziani Andreas Ferbert Imed Feki Andrés Caballero-Oteyza Alexandre Dionne-Laporte Mohamed Amri Anne Noreau Sylvie Forlani Vitor T Cruz Fanny Mochel Paula Coutinho Patrick Dion Chokri Mhiri Ludger Schols Jean Pouget Frédéric Darios Guy A Rouleau Wilson Marques Jr Alexis Brice Alexandra Durr Stephan Zuchner Giovanni Stevanin
Affiliations

Affiliation

  • 1 Service de Neurologie, Hôpital Universitaire Habib Bourguiba, 3029 Sfax, Tunisia.
Abstract

Hereditary spastic paraplegias (HSPs) form a heterogeneous group of neurological disorders. A whole-genome linkage mapping effort was made with three HSP-affected families from Spain, Portugal, and Tunisia and it allowed us to reduce the SPG26 locus interval from 34 to 9 Mb. Subsequently, a targeted capture was made to sequence the entire exome of affected individuals from these three families, as well as from two additional autosomal-recessive HSP-affected families of German and Brazilian origins. Five homozygous truncating (n = 3) and missense (n = 2) mutations were identified in B4GALNT1. After this finding, we analyzed the entire coding region of this gene in 65 additional cases, and three mutations were identified in two subjects. All mutated cases presented an early-onset spastic paraplegia, with frequent intellectual disability, cerebellar ataxia, and peripheral neuropathy as well as cortical atrophy and white matter hyperintensities on brain imaging. B4GALNT1 encodes β-1,4-N-acetyl-galactosaminyl transferase 1 (B4GALNT1), involved in ganglioside biosynthesis. These findings confirm the increasing interest of lipid metabolism in HSPs. Interestingly, although the catabolism of gangliosides is implicated in a variety of neurological diseases, SPG26 is only the second human disease involving defects of their biosynthesis.

Figures